Pharmacology
>> Metabolic Diseases
>>
Diet-Induced Obesity - C57BL/6J Mouse
-
Pharmacology
- Cardiovascular
-
Central Nervous System
- Acetylcholine / Acetic Acid - Induced Writhing
- Anti-Metrazole Seizure Test - Mouse
- Catalepsy - Mouse
- Chronic Constriction Injury - Rat, Mouse
- Hot Plate - Mouse
- Hot Water - Tail Dip - Mouse
- Incisional Pain - Mouse, Rat
- Induced Vomiting - Ferret
- Irwin Screen Rat or Mouse
- Partial Sciatic Nerve Ligation - Rat, Mouse
- Rotarod - Mouse, Rat
- Sleep Time - Mouse, Rat
- Spinal Nerve Ligation - Rat, Mouse
- Spontaneous Motor Activity - Mouse
- Tail Flick - Mouse
-
Gastrointestinal
- Charcoal Meal Test - Rat
- Colonic Propulsion Velocity
- Dextran Sulfate Sodium Induced Colitis - Mouse
- Fecal Pellet Output - Mouse
- Gastric Emptying - Polystyrene Bead Test - Rat
- Glass Bead Test - Mouse
- Induced Vomiting - Ferret
- Prevention of Induced Diarrhea - Rat, Mouse
- Prevention of Induced Gastric Lesions and Intestinal Lesions
- Pylorus - Ileal Ligated Rat
- Pylorus Ligated Rat
- Inflammation
- Metabolic Diseases
- Pharmacokinetics
- Testing Services
- Industries
- About PSL
Diet-Induced Obesity - C57BL/6J Mouse
The inbred mouse strain, C57BL/6J, is highly susceptible to development of obesity and diabetes upon feeding a high fat/high simple carbohydrate diet, whereas if left on normal chow, it will not develop metabolic syndrome. Obesity can be seen on the high fat/high simple carbohydrate diet after 10-12 weeks of treatment in which significant increases in body weight, adiposity and diabetes can be observed. Effects of anti-obesity (or anti-diabetic) drugs can be assessed by changes in body weight, body composition using DEXA as well as plasma glucose and insulin levels.